Victory Capital Management Inc Bio Xcel Therapeutics, Inc. Transaction History

Victory Capital Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 03, 2021	SELL	$29.06 - $38.83 $219,780 - $293,671	-7,563 Closed	0 $0
Q1 2021 May 04, 2021	SELL	$39.04 - $64.6 $26.4 Million - $43.8 Million	-677,426 Reduced 98.9%	7,563 $326,000
Q4 2020 Feb 01, 2021	BUY	$42.46 - $56.58 $3.85 Million - $5.13 Million	90,695 Added 15.26%	684,989 $31.6 Million
Q3 2020 Nov 09, 2020	BUY	$37.44 - $64.63 $22 Million - $38 Million	588,010 Added 9357.26%	594,294 $25.8 Million
Q2 2020 Aug 07, 2020	BUY	$17.62 - $58.71 $77,704 - $258,911	4,410 Added 235.33%	6,284 $333,000
Q1 2020 May 04, 2020	BUY	$12.26 - $41.14 $6,522 - $21,886	532 Added 39.64%	1,874 $42,000
Q4 2019 Feb 04, 2020	BUY	$4.05 - $14.61 $2,122 - $7,655	524 Added 64.06%	1,342 $22,000
Q3 2019 Nov 12, 2019	BUY	$7.04 - $11.77 $5,758 - $9,627	818 New	818 $6,000

3.14M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $11.5M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.